- Home
- ALF vs NPCE Comparison
ALF vs NPCE Comparison
Compare ALF & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALF
- NPCE
- Stock Information
- Founded
- ALF 2024
- NPCE 1997
- Country
- ALF United States
- NPCE United States
- Employees
- ALF N/A
- NPCE N/A
- Industry
- ALF
- NPCE Medical Specialities
- Sector
- ALF
- NPCE Health Care
- Exchange
- ALF NYSE
- NPCE Nasdaq
- Market Cap
- ALF 363.3M
- NPCE 427.9M
- IPO Year
- ALF 2024
- NPCE 2021
- Fundamental
- Price
- ALF $10.18
- NPCE $13.83
- Analyst Decision
- ALF
- NPCE Buy
- Analyst Count
- ALF 0
- NPCE 7
- Target Price
- ALF N/A
- NPCE $15.29
- AVG Volume (30 Days)
- ALF 12.5K
- NPCE 314.8K
- Earning Date
- ALF 01-01-0001
- NPCE 03-04-2025
- Dividend Yield
- ALF N/A
- NPCE N/A
- EPS Growth
- ALF N/A
- NPCE N/A
- EPS
- ALF N/A
- NPCE N/A
- Revenue
- ALF N/A
- NPCE $76,452,000.00
- Revenue This Year
- ALF N/A
- NPCE $24.08
- Revenue Next Year
- ALF N/A
- NPCE $16.82
- P/E Ratio
- ALF N/A
- NPCE N/A
- Revenue Growth
- ALF N/A
- NPCE 27.00
- 52 Week Low
- ALF $9.96
- NPCE $5.45
- 52 Week High
- ALF $10.25
- NPCE $17.37
- Technical
- Relative Strength Index (RSI)
- ALF N/A
- NPCE 56.44
- Support Level
- ALF N/A
- NPCE $10.30
- Resistance Level
- ALF N/A
- NPCE $14.39
- Average True Range (ATR)
- ALF 0.00
- NPCE 1.04
- MACD
- ALF 0.00
- NPCE -0.02
- Stochastic Oscillator
- ALF 0.00
- NPCE 83.13
About ALF CENTURION ACQUISITION CORP
Centurion Acquisition Corp is a blank check company.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System.